AB2 Bio (Switzerland)
Inflammation is a natural defense mechanism. However, dysregulated and persistent inflammatory processes are the basis of several chronic inflammatory and autoimmune diseases, such as: NLRC4 mutation and XIAP deficiency (primary HLH), Macrophage Activation Syndrome (secondary HLH), Adult onset Still's Disease and others. AB2 Bio Ltd.
Basic Information
- Category: business
- Website: http://www.ab2bio.com/en/home.8.html
Documented Facts
- Inception (Wikidata): 2010
- Country (Wikidata; date unspecified): Switzerland
- Official website (Wikidata; date unspecified): http://www.ab2bio.com/en/home.8.html
Evidence and Sources
- AB2 Bio (Switzerland) — Official Website (official)
- Wikidata Q30268708, revision 2474417315 (knowledge-base)
- Wikidata label: Q39, revision 2550802861 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about AB2 Bio (Switzerland).
- Canonical profile: https://brandsource.ai/brands/ab2-bio-switzerland
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/ab2-bio-switzerland/json-ld
- Citation profile API: https://brandsource.ai/api/brands/ab2-bio-switzerland/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Inflammation is a natural defense mechanism. However, dysregulated and persistent inflammatory processes are the basis of several chronic inflammatory and autoimmune diseases, such as: NLRC4 mutation and XIAP deficiency (primary HLH), Macrophage Activation Syndrome (secondary HLH), Adult onset Still's Disease and others. AB2 Bio Ltd.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.